Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$15.87
+6.87%
Mkt Cap $816.95M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (7 analysts)
$37.40
Range $35.00 – $40.00
Implied Upside
+135.7%
Consensus $37.40 vs current $15.87
NASDAQ·Healthcare·Biotechnology
$15.87
+6.87%
Mkt Cap $816.95M
Buy
3
Hold
0
Sell
0
Price Target (7 analysts)
$37.40
Range $35.00 – $40.00
+135.7%
Consensus $37.40 vs current $15.87